Valuation: LivaNova PLC

Market Cap 4.54B 3.97B 3.66B 3.38B 6.41B 433B 6.52B 43.72B 17.17B 213B 17.03B 16.66B 733B P/E 2026 *
29.6x
P/E 2027 * 25.6x
Enterprise Value 4.56B 3.98B 3.68B 3.39B 6.44B 434B 6.55B 43.91B 17.24B 214B 17.1B 16.73B 736B EV / Sales 2026 *
3.02x
EV / Sales 2027 * 2.71x
Free-Float
98.44%
Yield 2026 *
-
Yield 2027 * -
1 day+0.05%
1 week-1.27%
Current month+0.40%
1 month+5.33%
3 months+31.51%
6 months+28.18%
Current year+34.18%
1 week 81.5
Extreme 81.5
85.27
1 month 77.71
Extreme 77.71
85.27
Current year 56.44
Extreme 56.44
85.27
1 year 41.02
Extreme 41.015
85.27
3 years 32.48
Extreme 32.48
85.27
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 2024-02-29
Director of Finance/CFO 56 2020-10-30
Investor Relations Contact - 2022-07-31
Director TitleAgeSince
Director/Board Member 69 2015-10-18
Chairman 74 2021-06-08
Director/Board Member 62 2019-06-17
Date Insider Type Main position Quantity % Market Cap.
Jun. 14Fiscal year

Director

10,953 0.0199%
Jun. 14Fiscal year

Executive/Senior Manager

6,962 0.0127%
Jun. 14Fiscal year

Director

10,953 0.0199%
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%-1.27%+76.90%+59.17% 4.53B
-0.50%-1.54%-29.69%-12.23% 164B
+1.80%+0.82%-6.19%-2.98% 105B
+0.32%+2.34%+2.06%+57.36% 58.85B
+0.79%-3.68%+40.47%+55.85% 51.05B
+0.72%-3.88%-14.40%-41.01% 41.57B
+0.47%-4.98% - - 34.54B
+2.66%+5.21%-12.29%-42.61% 28.18B
-1.10%-3.29%+54.30%-6.25% 25.27B
-1.73%-3.06%-10.60%+1.91% 20.24B
Average +0.62%-0.84%+11.17%+7.69% 53.41B
Weighted average by Cap. +1.24%-0.84%-5.58%+2.29%

Financials

2026 *2027 *
Net sales 1.51B 1.32B 1.22B 1.12B 2.13B 144B 2.17B 14.54B 5.71B 70.86B 5.66B 5.54B 244B 1.61B 1.41B 1.3B 1.2B 2.28B 154B 2.32B 15.56B 6.11B 75.86B 6.06B 5.93B 261B
Net income 148M 130M 120M 111M 210M 14.15B 213M 1.43B 562M 6.97B 557M 545M 23.97B 179M 157M 145M 134M 254M 17.11B 258M 1.73B 679M 8.43B 674M 659M 28.99B
Net Debt 20.06M 17.54M 16.18M 14.95M 28.36M 1.91B 28.84M 193M 75.93M 942M 75.31M 73.67M 3.24B -167M -146M -135M -124M -236M -15.93B -240M -1.61B -632M -7.85B -627M -614M -26.98B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
26-07-10 $82.56 +0.05% 452,293
26-07-09 $82.52 +0.01% 612,071
26-07-08 $82.51 -1.28% 724,838
26-07-07 $83.58 -0.54% 439,563
26-07-06 $84.03 +0.49% 548,864
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
82.56USD
Average target price
81.45USD
Spread / Average Target
-1.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock